Presentation is loading. Please wait.

Presentation is loading. Please wait.

1. Diagnosis 2 Is based upon clinical signs and symptoms Is based upon clinical signs and symptoms.

Similar presentations


Presentation on theme: "1. Diagnosis 2 Is based upon clinical signs and symptoms Is based upon clinical signs and symptoms."— Presentation transcript:

1 1

2 Diagnosis 2

3 Is based upon clinical signs and symptoms Is based upon clinical signs and symptoms

4 Is Not Indicated in the initial evaluation Is Not Indicated in the initial evaluation  In the absence of signs suggesting complicated disease

5 5

6 6

7 Any patient with one major symptom and two minor symptoms Or Two major symptoms is diagnosed to have rhinosinusitis 7

8 Distinguishing bacterial from viral infection 8

9 No clear Data 9

10 10 Symptom duration and progression

11 1.Persistent symptoms or signs of ARS lasting 10 or more days without evidence of clinical improvement (Nasal discharge) 11

12 Symptoms often persistent for more than 10 days with a viral infection Symptoms often persistent for more than 10 days with a viral infection Typically there is some improvement in the clinical course by day 10 Typically there is some improvement in the clinical course by day 10 12

13 2.Onset of severe symptoms or signs of high fever (>39°C or 102°F) + Purulent nasal discharge Or Facial pain for at least three to four consecutive days at the beginning of illness. Facial pain for at least three to four consecutive days at the beginning of illness.13

14 Fever associated with a viral infection generally subsides in 24 48 hours Fever associated with a viral infection generally subsides in 24 to 48 hours Purulent nasal discharge usually occurs after four or five days Purulent nasal discharge usually occurs after four or five days

15 3.Onset with worsening symptoms or signs (new onset fever, headache, nasal discharge) o following a typical viral upper respiratory infection that lasted five to six days and were initially improving. 15

16 Persistent symptoms or signs of ARS ≥ 10 days Onset of severe symptoms or signs Worsening symptoms or signs after initial improvement Distinguishing bacterial from viral infection

17 Physical Examination 17

18 The usual evaluation for respiratory infection: The usual evaluation for respiratory infection:  Vital signs  Eyes, ears, pharynx, teeth, sinus tenderness, lymph nodes, and chest

19 Facial pain : more reliable in the diagnosis of rhinosinusitis Pain localized to the sinuses (bending forward) > provoked pain by percussion Pain localized to the sinuses (bending forward) > provoked pain by percussion Wilson JF. In the clinic. Acute sinusitis. Ann Intern Med 2010; 153:ITC31.

20 20 Handheld Otoscope Nasal Speculum

21 Diffuse mucosal edema Diffuse mucosal edema Narrowing of the middle meatus Narrowing of the middle meatus Inferior turbinate hypertrophy Inferior turbinate hypertrophy Copious rhinorrhea or purulent discharge Copious rhinorrhea or purulent discharge

22 Diagnostic Tests 22

23 Microbiologic culture Viral culture of nasal secretions is: Viral culture of nasal secretions is:  Impractical and unnecessary 23

24 Bacterial culture Blind swabs of the nasal cavity Blind swabs of the nasal cavity Purulent nasal secretions Purulent nasal secretions  Is not recommended  As results are not reliable 24

25 Cultures (obtained by endoscopy) are indicated in patients with documented sinusitis: Cultures (obtained by endoscopy) are indicated in patients with documented sinusitis:  who are not responding to empiric antibiotic therapy  A suspicion of intracranial extension of the infection or other serious complications 25 Endoscopic image of purulent drainage from the middle meatus in a patient with acute bacterial rhinosinusitis

26 Radiologic studies Radiologic studies

27 Radiography of any modality is not indicated in the initial evaluation of uncomplicated acute rhinosinusitis (ARS) Radiography of any modality is not indicated in the initial evaluation of uncomplicated acute rhinosinusitis (ARS)

28 Indication the Radiologic studies Complicated ABRS Complicated ABRS

29 Indication the Radiologic studies Recurrent or treatment- resistant sinusitis Recurrent or treatment- resistant sinusitis

30 Indication the Radiologic studies Helping delineate anatomic blockage of the ostio-meatal complex Helping delineate anatomic blockage of the ostio-meatal complex

31 Water’s position for sinus

32 The high false-negative rate of Water’s position for sinus Poor visualization of the ethmoid sinuses Poor visualization of the ethmoid sinuses

33 The high false-positive rate of Water’s position for sinus Artifact Artifact  The inability to distinguish polyps and nasal masses from fluid or mucosal edema

34 Coronal CT scan of sinuses

35 Coronal CT scan of sinuses revealing sinusitis bilaterally with fluid level in the left maxilla

36 MRI and CT are considered complementary studies for the evaluation of possible orbital or intracranial complications of ABRS MRI scan of brain Extensive destruction of roof of left ethmoidal sinus with brain contents extending into the nose

37 Treatment

38 Supportive care AVRS treatment  Mild analgesics  Saline nasal irrigation and fluid 38

39 Supportive care AVRS treatment  Intranasal glucocorticoids 39

40 Decongestants - AVRS treatment Decongestants may be useful when Eustachian tube dysfunction is a factor for patients with AVRS Decongestants may be useful when Eustachian tube dysfunction is a factor for patients with AVRS Are not likely to be helpful for patients with ABRS and have adverse side effects Are not likely to be helpful for patients with ABRS and have adverse side effects40

41 Antihistamines - AVRS treatment We suggest not treating symptoms with antihistamines (Grade 2C ) We suggest not treating symptoms with antihistamines (Grade 2C )41

42 ABRS treatment We recommend treatment with an antibiotic for patients whose clinical symptoms meet criteria for ABRS We recommend treatment with an antibiotic for patients whose clinical symptoms meet criteria for ABRS42

43 ABRS treatment Initial empiric treatment with Amoxicillin-clavulanate rather than Macrolides Initial empiric treatment with Amoxicillin-clavulanate rather than Macrolides43

44 ABRS treatment Doxycycline is a reasonable alternative for first-line therapy Doxycycline is a reasonable alternative for first-line therapy Can be used in patients with penicillin allergy Can be used in patients with penicillin allergy44

45 ABRS treatment A respiratory fluoroquinolone: A respiratory fluoroquinolone:  ( Levofloxacin or Moxifloxacin ) is another option for penicillin-allergic patients. 45

46 Local and regional histograms of bacterial resistance - ABRS treatment To understand resistance trends in the local community To understand resistance trends in the local community46

47 No indication for surgery in patients with uncomplicated ABRS 47

48 Surgery may be emergently indicated in patients experiencing Surgery may be emergently indicated in patients experiencing  Extra-sinus complications of ABRS: Orbital abscess Orbital abscess Epidural abscess Epidural abscess Meningitis Meningitis Brain abscess Brain abscess 48

49 49

50 50 Allergic Rhinitis

51 51 Rhinitis: Symptomatic disorder of the nose characterized by itching, nasal discharge, sneezing and nasal airway obstruction Allergic rhinitis: Induction of rhinitis symptoms after allergen exposure by an IgE-mediated immune reaction; accompanied by inflammation of the nasal mucosa and nasal airway hyperreactivity. www.worldallergy.org/gloria

52 52 Allergic Rhinitis Co-Morbidities Conjunctivitis Sinusitis Otitis Media Cough Asthma www.worldallergy.org/gloria

53 53 ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA ARIA JACI 2001:56: 813-824

54 54 Intermittent Symptoms < 4 days / week or < 4 weeks Persistent Symptoms > 4 days / week or > 4 weeks Mild Sleep: normal Daily activities (incl. sports): normal Work-school activities: normal Severe symptoms: no Moderate- severe Sleep: disturbed Daily activities: Restricted Work and school activities: disrupted Severe symptoms: yes Allergic Rhinitis Classification www.worldallergy.org/gloria

55 55 Globally Important Sources of Allergens House dust mites Grass, tree and weed pollen Pets Cockroaches Molds www.worldallergy.org/gloria

56 56 Diagnosis of Allergic Rhinitis Detailed personal and family allergic history Intranasal examination – anterior rhinoscopy Symptoms of other allergic diseases Allergy skin tests and/or In vitro specific IgE tests www.worldallergy.org/gloria

57 57 Allergy Skin Prick Testing Skin prick test / positive result www.worldallergy.org/gloria

58 58 Primary Ab Secondary Ab Enzyme Sample to be measured Substrate Concept of In Vitro IgE Assays www.worldallergy.org/gloria

59 59 MANAGEMENT OF ALLERGIC RHINITIS

60 60 Environmental Control House dust mites Pets Cockroaches Molds Pollen 1. Allergens 2. Pollutants and Irritants www.worldallergy.org/gloria

61 61 Allergen Avoidance Pets Remove pets from bedrooms and, even better, from the entire home Vacuum carpets, mattresses and upholstery regularly Wash pets regularly (±) Molds Ensure dry indoor conditions Use ammonia to remove mold from bathrooms and other wet spaces Cockroaches Eradicate cockroaches with appropriate gel-type, non-volatile, insecticides Eliminate dampness, cracks in floors, ceilings, cover food; wash surfaces, fabrics to remove allergen Pollen Remain indoors with windows closed at peak pollen times Wear sunglasses Use air-conditioning, where possible Install car pollen filter www.worldallergy.org/gloria

62 62 House dust mite allergen avoidance  Provide adequate ventilation to decrease humidity  Wash bedding regularly at 60°C  Encase pillow, mattress and quilt in allergen impermeable covers  Use vacuum cleaner with HEPA filter  Dispose of feather bedding  Remove carpets  Remove curtains, pets and stuffed toys from bedroom www.worldallergy.org/gloria

63 63 PHARMACOTHERAPY OF ALLERGIC RHINITIS www.worldallergy.org/gloria

64 64 Oral Antihistamines First generation agents Chlorpheniramine Brompheniramine Diphenydramine Promethazine Tripolidine Hydroxyzine Azatadine Newer agents Acrivastine Azelastine Cetirizine Desloratadine Fexofenadine Levocetirizine Loratadine Mizolastine www.worldallergy.org/gloria

65 65 Nasal Antihistamines Azelastine Levocabastine Olopatadine www.worldallergy.org/gloria

66 66 Decongestants: Alpha-2 Adrenergic Agonists Oral Pseudoephedrine Nasal Phenylephrine Oxymetazoline Xylometazoline www.worldallergy.org/gloria

67 67 Anti-Leukotriene Agents * Approved for allergic rhinitis

68 68 Nasal Corticosteroids Most potent anti-inflammatory agents Effective in treatment of all nasal symptoms including obstruction Superior to anti-histamines and anti-leukotienes First line pharmacotherapy for persistent allergic rhinitis www.worldallergy.org/gloria

69 69 Allergen Immunotherapy (Vaccines) Subcutaneous Sublingual Nasal www.worldallergy.org/gloria

70 70


Download ppt "1. Diagnosis 2 Is based upon clinical signs and symptoms Is based upon clinical signs and symptoms."

Similar presentations


Ads by Google